Literature DB >> 9331075

Selection of human cervical epithelial cells that possess reduced apoptotic potential to low-oxygen conditions.

C Y Kim1, M H Tsai, C Osmanian, T G Graeber, J E Lee, R G Giffard, J A DiPaolo, D M Peehl, A J Giaccia.   

Abstract

Since human papillomavirus (HPV) infection is strongly associated with cervical neoplasia and tumor hypoxia has prognostic significance in human cervical carcinomas, we examined the relationship between hypoxia and apoptosis in human cervical epithelial cells expressing high-risk HPV type 16 oncoproteins. In vitro, hypoxia stimulated both p53 induction and apoptosis in primary cervical epithelial cells infected with the HPV E6 and E7 genes but not in cervical fibroblasts infected with E6 and E7. Furthermore, cell lines derived from HPV-associated human cervical squamous cell carcinomas were substantially less sensitive to apoptosis induced by hypoxia, indicating that these cell lines have acquired additional genetic alterations that reduced their apoptotic sensitivity. Although the process of long-term cell culturing resulted in selection for subpopulations of HPV oncoprotein-expressing cervical epithelial cells with diminished apoptotic potential, the exposure of cells to hypoxia greatly accelerated the selection process. These results provide evidence for the role of hypoxia-mediated selection of cells with diminished apoptotic potential in the progression of human tumors and can in part explain why cervical tumors that possess low pO2 values are more aggressive.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9331075

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  35 in total

Review 1.  Causes and effects of heterogeneous perfusion in tumors.

Authors:  R J Gillies; P A Schornack; T W Secomb; N Raghunand
Journal:  Neoplasia       Date:  1999-08       Impact factor: 5.715

2.  An evolutionary hybrid cellular automaton model of solid tumour growth.

Authors:  P Gerlee; A R A Anderson
Journal:  J Theor Biol       Date:  2007-02-12       Impact factor: 2.691

3.  Computational modeling on the recognition of the HRE motif by HIF-1: molecular docking and molecular dynamics studies.

Authors:  Pandian Sokkar; Vani Sathis; Murugesan Ramachandran
Journal:  J Mol Model       Date:  2011-08-05       Impact factor: 1.810

4.  Apoptosis in cervical squamous carcinoma: predictive value for survival following radiotherapy.

Authors:  J R Paxton; B S Bolger; A Armour; R P Symonds; J H Mao; R A Burnett
Journal:  J Clin Pathol       Date:  2000-03       Impact factor: 3.411

Review 5.  Treatment resistance of solid tumors: role of hypoxia and anemia.

Authors:  P Vaupel; O Thews; M Hoeckel
Journal:  Med Oncol       Date:  2001       Impact factor: 3.064

6.  p53 directly suppresses BNIP3 expression to protect against hypoxia-induced cell death.

Authors:  Xi Feng; Xing Liu; Wei Zhang; Wuhan Xiao
Journal:  EMBO J       Date:  2011-07-26       Impact factor: 11.598

7.  Modulation of type M2 pyruvate kinase activity by the human papillomavirus type 16 E7 oncoprotein.

Authors:  W Zwerschke; S Mazurek; P Massimi; L Banks; E Eigenbrodt; P Jansen-Dürr
Journal:  Proc Natl Acad Sci U S A       Date:  1999-02-16       Impact factor: 11.205

Review 8.  Response of tumour cells to hypoxia: role of p53 and NFkB.

Authors:  J A Royds; S K Dower; E E Qwarnstrom; C E Lewis
Journal:  Mol Pathol       Date:  1998-04

9.  Counteraction of pRb-dependent protection after extreme hypoxia by elevated ribonucleotide reductase.

Authors:  P Graff; J Seim; Ø Amellem; H Arakawa; Y Nakamura; K K Andersson; T Stokke; E O Pettersen
Journal:  Cell Prolif       Date:  2004-10       Impact factor: 6.831

10.  Hypoxia-inducible erythropoietin signaling in squamous dysplasia and squamous cell carcinoma of the uterine cervix and its potential role in cervical carcinogenesis and tumor progression.

Authors:  Geza Acs; Paul J Zhang; Cindy M McGrath; Peter Acs; John McBroom; Ahmed Mohyeldin; Suzhen Liu; Huasheng Lu; Ajay Verma
Journal:  Am J Pathol       Date:  2003-06       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.